128 / Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, Feugier P, Rabian C, Casasnovas O, Labalette M, Kuhlein E, Farcet JP, Emile JF, Gisselbrecht C, Delfau-Larue MH; Groupe d'étude des lymphomes de l'adulte. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol. 2007 Jul;18(7):1209-15. Epub 2007 May 12. http://www.ncbi.nlm.nih.gov 127 / Mounier N, Spina M, Gisselbrecht C. Modern management of non-Hodgkin lymphoma in HIV-infected patients. Br J Haematol. 2007 Mar;136(5):685-98. Epub 2006 Dec 1. http://www.ncbi.nlm.nih.gov 126 / Fermé C, Brice P, Michallet AS, Lederlin P, Diviné M, Casasnovas O, Devidas A, Anglaret B, Cazals-Hatem D, Mounier N; Groupe d'Etudes des Lymphomes de L'adulte. A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Leuk Lymphoma. 2007 Apr;48(4):691-8.ng http://www.ncbi.nlm.nih.gov 125 / Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, de Mascarel A, Hemery F, Gaulard P, Delchier JC; Groupe d'Etude des Lymphomes de l'Adulte (GELA). Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. 1: Am J Gastroenterol. 2002 Feb;97(2):292-7 http://www.ncbi.nlm.nih.gov 124 / Diviné M, Casassus P, Koscielny S, Bosq J, Sebban C, Le Maignan C, Stamattoulas A, Dupriez B, Raphaël M, Pico JL, Ribrag V; GELA; GOELAMS. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol Ann Oncol. 2005 Dec;16(12):1928-35. Epub 2005 Nov 10. http://www.ncbi.nlm.nih.gov 123 / de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, Lamant L, Leroy K, Brière J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007 Jun 1;109(11):4952-63. Epub 2007 Feb 6 http://www.ncbi.nlm.nih.gov 122 / Coiffier B. Rituximab therapy in malignant lymphoma. Oncogene. 2007 May 28;26(25):3603-13 http://www.ncbi.nlm.nih.gov 121 / Thieblemont C, Coiffier B. Lymphoma in older patients. J Clin Oncol. 2007 May 10;25(14):1916-23 http://www.ncbi.nlm.nih.gov 120 / Bonnet C, Fillet G, Mounier N, Ganem G, Molina TJ, Thiéblemont C, Fermé C, Quesnel B, Martin C, Gisselbrecht C, Tilly H, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2007 Mar 1;25(7):787-92. Epub 2007 Jan 16. http://www.ncbi.nlm.nih.gov 119 / Lamant L, de Reyniès A, Duplantier MM, Rickman DS, Sabourdy F, Giuriato S, Brugières L, Gaulard P, Espinos E, Delsol G. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood. 2007 Mar 1;109(5):2156-64. Epub 2006 Oct 31. http://www.ncbi.nlm.nih.gov 118 / Coiffier B. Rituximab and CHOP-like chemotherapy in good-prognosis diffuse large-B-cell lymphoma. Nat Clin Pract Oncol. 2006 Nov;3(11):594-5. No abstract available. http://www.ncbi.nlm.nih.gov 117 / Coiffier B. Standard treatment of advanced-stage diffuse large B-cell lymphoma. Semin Hematol. 2006 Oct;43(4):213-20 http://www.ncbi.nlm.nih.gov 116 / Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA, Briere J, Baglin AC, Cheze S, Bosq J, Ribrag V, Gisselbrecht C, Mounier N, Gaulard P. Departement de Pathologie et Inserm U617, Hopital Henri Mondor, France. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma : results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2006 Oct 31; http://www.ncbi.nlm.nih.gov 115 / Coiffier B. Treatment of non-Hodgkin's lymphoma: a look over the past decade. Clin Lymphoma Myeloma. 2006 Oct;7 Suppl 1:S7-13 http://www.ncbi.nlm.nih.gov 114 / Sebban C, Mounier N, Brousse N, Belanger C, Brice P, Haioun C, Tilly H, Feugier P, Bouabdallah R, Doyen C, Salles G, Coiffier B. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood. 2006 Oct 15;108(8):2540-4. Epub 2006 Jul 11. 113 / Dupuis J, Emile JF, Mounier N, Gisselbrecht C, Martin-Garcia N, Petrella T, Bouabdallah R, Berger F, Delmer A, Coiffier B, Reyes F, Gaulard P. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Goupe d' Eude des Lmphomes de l' Adulte (GELA) study. Blood. 2006 Aug 10; [Epub ahead of print] 112 / Ferme C, Mounier N, Casasnovas O, Brice P, Divine M, Sonet A, Bouafia F, Bastard-Stamatoullas A, Bordessoule D, Voillat L, Reman O, Blanc M, Gisselbrecht C; Groupe d'Etude des Lymphomes de l'Adulte. Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood. 2006 Jun 15;107(12):4636-42. Epub 2006 Feb 14. 111 / Hagberg H, Gisselbrecht C; CORAL study group. Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Ann Oncol. 2006 May;17 Suppl 4:iv31-2. http://www.ncbi.nlm.nih.gov 110 / Mounier N, Spina M, Gabarre J, Raphael M, Rizzardini G, Golfier JB, Vaccher E, Carbone A, Coiffier B, Chichino G, Bosly A, Tirelli U, Gisselbrecht C. AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood. 2006 May 15;107(10):3832-40. Epub 2006 Jan 12. 109 / Mounier N, Briere J, Gisselbrecht C, Reyes F, Gaulard P, Coiffier B; Groupe d'Etude des Lymphomes de l'Adulte. Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma. Haematologica. 2006 May;91(5):715-6. 108 / Hagberg H, Gisselbrecht C; CORAL study group. Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Ann Oncol. 2006 May;17 Suppl 4:iv31-2. 107 / Gisselbrecht C, Mounier N. Managing large cell lymphoma. Ann Oncol. 2006 May;17 Suppl 4:iv8-11. 106 / Mounier N, Briere J, Gisselbrecht C, Reyes F, Gaulard P, Coiffier B. Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma. Haematologica. 2006 Apr 3; [Epub ahead of print] 105 / Coiffier B. Monoclonal antibody as therapy for malignant lymphomas. C R Biol. 2006 Apr;329(4):241-54. Epub 2006 Mar 20. Review. 104 / Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loi L, Loriod B, Bertucci F, Bouabdallah R, Devilard E, Carbuccia N, Mozziconacci MJ, Birnbaum D, Brousset P, Berger F, Salles G, Briere J, Houlgatte R, Gaulard P, Xerri L. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene. 2006 Mar 9;25(10):1560-70. 103 / Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, Reyes F, Hermine O; Groupe d'Etude des Lymphomes de l'Adulte Programs. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol. 2006 Feb 20;24(6):953-60. Epub 2006 Jan 17. 102 / Meignan M, Haioun C, Itti E, Rahmouni A, Reyes F. Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma. 2006 Jan;6(4):306-13. Review. 101 / Nicolas Mounier, Michele Spina, Jean Gabarre, Martine Raphael, Giuliano Rizzardini, Jean-Baptiste Golfier, Emanuela Vaccher, Antonino Carbone, Bertrand Coiffier, Guido Chichino, Andre Bosly, Umberto Tirelli, and Christian Gisselbrecht. AIDS-related non-Hodgkin's lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood First Edition Paper, prepublished online January 12, 2006; DOI 10.1182/blood-2005-09-3600. http://www.bloodjournal.org 100 / Ruiz-Soto R, Sergent G, Gisselbrecht C, Larghero J, Ertault M, Hennequin C, Manson J, de Kerviler E, Briere J, Mounier N. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients. Cancer. 2005 Dec 15;104(12):2735-42. 99 / Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood. 2005 Aug 15;106(4):1376-81. Epub 2005 Apr 28. 98 / Gisselbrecht C, Mounier N, Andre M, Casanovas O, Reman O, Sebban C, Divine M, Brice P, Briere J, Hennequin C, Ferme C. How to define intermediate stage in Hodgkin's lymphoma ? Eur J Haematol Suppl. 2005 Jul;(66):111-4. 97 / Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, Christian B, Lepage E, Tilly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gisselbrecht C, Reyes F, Coiffier B. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2005 Jun 20;23(18):4117-26. Epub 2005 May 2. 96 / Coiffier B, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective. Oncology (Williston Park). 2005 Apr;19(4 Suppl 1):7-15. Review. 95 / Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005 Mar 24;352(12):1197-205. http://www.ncbi.nlm.nih.gov 94 / Fabiani B, Delmer A, Lepage E, Guettier C, Petrella T, Briere J, Penny AM, Copin MC, Diebold J, Reyes F, Gaulard P, Molina TJ; Groupe d'Etudes des Lymphomes de l'Adulte. Departement de Pathologie, Hopital Saint-Antoine, AP-HP, Paris, France. CD10 expression in diffuse large B-cell lymphomas does not influence survival. Virchows Arch. 2004 Dec;445(6):545-51. Epub 2004 Oct 27 http://www.ncbi.nlm.nih.gov 93 / Mounier N, Gisselbrecht C, Briere J, Haioun C, Feugier P, Offner F, Recher C, Stamatoullas A, Morschhauser F, Macro M, Thieblemont C, Sonet A, Fabiani B, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Hopital Saint Louis, AP-HP, Paris, France. nicolas.mounier@sls.ap-hop-paris.fr All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Ann Oncol. 2004 Dec;15(12):1790-7. http://www.ncbi.nlm.nih.gov 92 / S Camilleri-Broët1,2, N Mounier3, A Delmer4, J Brière5, O Casasnovas6, L Cassard2, P Gaulard7, B Christian8, B Coiffier9 and C Sautès-Fridman2 FcRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP) Leukemia. 2004 Dec;18(12):2038-40 http://www.nature.com 91 / Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haioun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E. Follicular lymphoma international prognostic index. Blood. 2004 Sep 1;104(5):1258-65. Epub 2004 May 4. 90 / Mounier N, Gisselbrecht C, Briere J, Haioun C, Feugier P, Offner F, Recher C, Stamatoullas A, Morschhauser F, Macro M, Thieblemont C, Sonet A, Fabiani B, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Service d'Onco-Hematologie, INSERM ERM0220, Hopital Saint Louis, AP-MP, 1 Avenue Claude Vellefaux, 75010 Paris, France. nicolas.mounier@sls.ap-hop-paris.fr Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2004 Jul 15;22(14):2826-34. http://www.ncbi.nlm.nih.gov 89 / Binn M, Ruskone-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, Lavergne A, Guettier C, Delchier JC. Hopital Henri Mondor, Gastroenterologie, Creteil, Val de Marne, France. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003 Dec;14(12):1751-7. http://www.ncbi.nlm.nih.gov 88 / Bertrand Coiffier, Nicolas Mounier, Serge Bologna, Christophe Fermé, Hervé Tilly, Anne Sonet, Bernard Christian, Olivier Casasnovas, Eric Jourdan, Karim Belhadj, Raoul Herbrecht From the Centre Hospitalier Lyon-Sud, Pierre-Bénite; Hôpital Saint-Louis, Paris; Centre Hospitalier Universitaire de Brabois, Vandoeuvre les Nancy; Institut Gustave Roussy, Villejuif; Centre Becquerel, Rouen; Hôpital Bon Secours, Metz; Centre Hospitalier du Bocage, Dijon; Centre Hospitalier de Nîmes, Nîmes; Hôpital Henri Mondor, Créteil; Hôpital de Hautepierre, Strasbourg, France; and Université Catholique de Louvain-Mont Godinne, Yvoir, Belgium. Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4402-4406 http://www.jco.org 87 / Marc P Andre*, Nicolas Mounier, Xavier Leleu, Anne Sonet, Pauline Brice, Michel Henry-Amar, Herve Tilly, Bertrand Coiffier, Andre Bosly, Pierre Morel, Corinne Haioun, Philippe Gaulard, Felix Reyes, and Christian Gisselbrecht Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen. A GELA cohort study on 2837 patients Blood First Edition Paper, prepublished online October 23, 2003; DOI 10.1182/blood-2003-04-1124. http://www.bloodjournal.org 86 / Gisselbrecht C, Mounier N, Ferme C, Brice P. Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma: a GELA experience. Ann Oncol. 2003;14 Suppl 1:i39-41 http://annonc.oupjournals.org 85 / P. Feugier1,*, J. M. Virion2, H. Tilly3, C. Haioun4, G. Marit5, M. Macro6, D. Bordessoule7, C. Recher8, M. Blanc9, T.